Vishnukant Bhutada, Managing Director at Shilpa Medicare said the company is working with Dr Reddy's Laboratories for 10 crore doses of Sputnik V vaccine per year. He added that the pricing of the vaccine is confidential.
"We have two platforms ready with us, one tied up with DRL. Probably by September-October, we should be able to give them the final product. For another platform, we are working with various companies," Bhutada said in an interview with CNBC-TV18.
He also announced a launch of an oral thin film of paracetamol under the brand 'Molshil' for paediatric use. "We are the first company to launch film formulations in India. We have done all the clinical trials," he added.
The Paracetamol market is very huge and the paediatric market is around 15-20 percent. There is a huge potential for this product in the market. "We personally feel that there is a great potential in this," he mentioned.
For the full interview, watch the accompanying video.
(Edited by : Priyanka Rathi)
First Published: IST